Intellia Therapeutics NTLA
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 8.99 | 671 | -13.49 | -96 | -10.84 | 842 |
| 2025Q3 | 17.27 | 748 | -13.85 | -101 | -11.11 | 925 |
| 2025Q2 | 9.38 | 715 | -13.54 | -101 | -10.74 | 899 |
| 2025Q1 | 7.11 | 780 | -13.84 | -114 | -10.50 | 986 |
| 2024Q4 | 11.66 | 872 | -14.05 | -129 | -10.90 | 1,191 |
| 2024Q3 | 20.55 | 963 | -14.04 | -136 | -11.48 | 1,173 |
| 2024Q2 | 22.38 | 971 | -14.64 | -147 | -11.99 | 1,192 |
| 2024Q1 | 27.51 | 1,036 | -10.30 | -107 | -8.39 | 1,260 |
| 2023Q4 | 30.49 | 1,050 | -12.66 | -132 | -10.39 | 1,301 |
| 2023Q3 | 31.62 | 1,037 | -11.41 | -122 | -9.52 | 1,243 |
| 2023Q2 | 40.78 | 1,105 | -10.77 | -124 | -9.02 | 1,323 |
| 2023Q1 | 37.27 | 1,191 | -8.50 | -103 | -7.02 | 1,418 |
| 2022Q4 | 34.89 | 1,236 | -11.01 | -113 | -8.71 | 1,520 |
| 2022Q3 | 55.96 | 825 | -13.28 | -113 | -10.32 | 1,084 |
| 2022Q2 | 51.76 | 881 | -10.98 | -101 | -8.70 | 1,110 |
| 2022Q1 | 72.67 | 954 | -14.73 | -147 | -11.76 | 1,203 |
| 2021Q4 | 118.24 | 1,040 | -7.57 | -81 | -6.18 | 1,294 |
| 2021Q3 | 134.15 | 1,107 | -8.94 | -72 | -7.14 | 1,335 |
| 2021Q2 | 161.91 | 495 | -13.22 | -69 | -9.91 | 672 |
| 2021Q1 | 80.26 | 546 | -8.61 | -46 | -6.63 | 717 |